LEGN ▲ +0.4% - Legend Biotech Corporation
$LEGN - Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion
25-SEP-2026 07:00 AM ET
Share this post
More filings for $LEGN
LEGN ▲ +3.2% - Legend Biotech CorporationNov 4, 2026LEGN ▼ -0.5% - Legend Biotech CorporationOct 27, 2026LEGN ▲ +0.3% - Legend Biotech CorporationOct 1, 2026LEGN ▲ +1.1% - Legend Biotech CorporationSep 15, 2026LEGN ▲ +0.9% - Legend Biotech CorporationSep 10, 2026LEGN ▼ -1.4% - Legend Biotech CorporationSep 1, 2026
View full $LEGN filing history →💬 Comments
Loading comments…
Leave a comment